{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:25:23Z","timestamp":1792754723176,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T00:00:00Z","timestamp":1421366400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12933-015-0174-7","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T15:22:54Z","timestamp":1421335374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation"],"prefix":"10.1186","volume":"14","author":[{"given":"Shiro","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kashine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takekazu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuyuki","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Imagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Funahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,16]]},"reference":[{"key":"174_CR1","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.diabres.2012.01.020","volume":"96","author":"A Hirata","year":"2012","unstructured":"Hirata A, Kishida K, Nakatsuji H, Hiuge-Shimizu A, Funahashi T, Shimomura I. Metabolic syndrome correlates with polyvascular lesions detected by systemic vascular ultrasonography in Japanese people with type 2 diabetes. Diabetes Res Clin Pract. 2012;96:e26\u20139.","journal-title":"Diabetes Res Clin Pract"},{"key":"174_CR2","unstructured":"World Health Organization. Obesity and overweight; WHO Fact Sheet No311; 2013. [http:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en\/index.html]"},{"key":"174_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","volume":"87","author":"JE Shaw","year":"2010","unstructured":"Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4\u201314.","journal-title":"Diabetes Res Clin Pract"},{"key":"174_CR4","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/S0140-6736(06)69703-1","volume":"368","author":"KH Yoon","year":"2006","unstructured":"Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681\u20138.","journal-title":"Lancet"},{"key":"174_CR5","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1001\/jama.2009.726","volume":"301","author":"JC Chan","year":"2009","unstructured":"Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia. Epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129\u201340.","journal-title":"JAMA"},{"key":"174_CR6","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.2337\/dc07-0218","volume":"30","author":"Y Okauchi","year":"2007","unstructured":"Okauchi Y, Nishizawa H, Funahashi T, Ogawa T, Noguchi M, Ryo M, et al. Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care. 2007;30:2392\u20134.","journal-title":"Diabetes Care"},{"key":"174_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jdi.12078","volume":"4","author":"Y Obata","year":"2013","unstructured":"Obata Y, Yamada Y, Kyo M, Takahi Y, Saisho K, Tamba S, et al. Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes. J Diabetes Investig. 2013;4:475\u201382.","journal-title":"J Diabetes Investig"},{"key":"174_CR8","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","volume":"20","author":"K Hotta","year":"2000","unstructured":"Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"174_CR9","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","volume":"291","author":"T Pischon","year":"2004","unstructured":"Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730\u20137.","journal-title":"JAMA"},{"key":"174_CR10","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/ajcn\/87.5.1134","volume":"87","author":"MD Tsiros","year":"2008","unstructured":"Tsiros MD, Sinn N, Brennan L, Coates AM, Walkley JW, Petkov J, et al. Cognitive behavioral therapy improves diet and body composition in overweight and obese adolescents. Am J Clin Nutr. 2008;87:1134\u201340.","journal-title":"Am J Clin Nutr"},{"key":"174_CR11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ajcn\/75.3.476","volume":"75","author":"NP Hays","year":"2002","unstructured":"Hays NP, Bathalon GP, McCrory MA, Roubenoff R, Lipman R, Roberts SB. Eating behavior correlates of adult weight gain and obesity in healthy women aged 55\u201365 y. Am J Clin Nutr. 2002;75:476\u201383.","journal-title":"Am J Clin Nutr"},{"key":"174_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2337\/diacare.28.2.451","volume":"28","author":"M Ryo","year":"2005","unstructured":"Ryo M, Maeda K, Onda T, Katashima M, Okumiya A, Nishida M, et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care. 2005;28:451\u20133.","journal-title":"Diabetes Care"},{"key":"174_CR13","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"174_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","volume":"257","author":"Y Arita","year":"1999","unstructured":"Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"174_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.atherosclerosis.2011.08.043","volume":"219","author":"A Hirata","year":"2011","unstructured":"Hirata A, Kishida K, Hiuge-Shimizu A, Nakatsuji H, Funahashi T, Shimomura I. Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes. Atherosclerosis. 2011;219:623\u20139.","journal-title":"Atherosclerosis"},{"key":"174_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.atherosclerosis.2008.08.026","volume":"204","author":"N Katakami","year":"2009","unstructured":"Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Yasuda T, et al. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. Atherosclerosis. 2009;204:288\u201392.","journal-title":"Atherosclerosis"},{"key":"174_CR17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1253\/circj.66.987","volume":"66","author":"Examination Committee of Criteria for \u2018Obesity Disease\u2019 in Japan","year":"2002","unstructured":"Examination Committee of Criteria for \u2018Obesity Disease\u2019 in Japan, Japan Society for the Study of Obesity. New criteria for \u2018obesity disease\u2019 in Japan. Circ J. 2002;66:987\u201392.","journal-title":"Circ J"},{"key":"174_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1079\/NRR19930010","volume":"6","author":"JP Despr\u00e9s","year":"1993","unstructured":"Despr\u00e9s JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev. 1993;6:137\u201359.","journal-title":"Nutr Res Rev"},{"key":"174_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5551\/jat.E580","volume":"15","author":"T Teramoto","year":"2008","unstructured":"Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, et al. Metabolic syndrome. J Atheroscler Thromb. 2008;15:1\u20135.","journal-title":"J Atheroscler Thromb"},{"key":"174_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1475-2840-10-109","volume":"10","author":"K Inoue","year":"2011","unstructured":"Inoue K, Maeda N, Kashine S, Fujishima Y, Kozawa J, Hiuge-Shimizu A, et al. Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes. Cardiovasc Diabetol. 2011;10:109.","journal-title":"Cardiovasc Diabetol"},{"key":"174_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1475-2840-11-107","volume":"11","author":"Y Fujishima","year":"2012","unstructured":"Fujishima Y, Maeda N, Inoue K, Kashine S, Nishizawa H, Hirata A, et al. Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes. Cardiovasc Diabetol. 2012;11:107.","journal-title":"Cardiovasc Diabetol"},{"key":"174_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5551\/jat.7625","volume":"18","author":"K Kishida","year":"2011","unstructured":"Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I. Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb. 2011;18:592\u20135.","journal-title":"J Atheroscler Thromb"},{"key":"174_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","volume":"221","author":"K Maeda","year":"1996","unstructured":"Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996;221:286\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"174_CR24","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","volume":"100","author":"N Ouchi","year":"1999","unstructured":"Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473\u20136.","journal-title":"Circulation"},{"key":"174_CR25","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1161\/01.CIR.0000018622.84402.FF","volume":"105","author":"Y Arita","year":"2002","unstructured":"Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002;105:2893\u20138.","journal-title":"Circulation"},{"key":"174_CR26","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/01.CIR.103.8.1057","volume":"103","author":"N Ouchi","year":"2001","unstructured":"Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 2001;103:1057\u201363.","journal-title":"Circulation"},{"key":"174_CR27","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","volume":"106","author":"Y Okamoto","year":"2002","unstructured":"Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002;106:2767\u201370.","journal-title":"Circulation"},{"key":"174_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1475-2840-13-103","volume":"13","author":"EZ Fisman","year":"2014","unstructured":"Fisman EZ, Tenenbaum A. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol. 2014;13:103.","journal-title":"Cardiovasc Diabetol"},{"key":"174_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12933-014-0130-y","volume":"13","author":"C Menzaghi","year":"2014","unstructured":"Menzaghi C, Xu M, Salvemini L, De Bonis C, Palladino G, Huang T, et al. Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism. Cardiovasc Diabetol. 2014;13:130.","journal-title":"Cardiovasc Diabetol"},{"key":"174_CR30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/HJR.0b013e32833b09d9","volume":"18","author":"SG Wannamethee","year":"2011","unstructured":"Wannamethee SG, Welsh P, Whincup PH, Sawar N, Thomas MC, Gudnarsson V, et al. High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? Eur J Cardiovasc Prev Rehabil. 2011;18:65\u201371.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"174_CR31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/cvr\/cvp415","volume":"86","author":"N Komura","year":"2010","unstructured":"Komura N, Kihara S, Sonoda M, Maeda N, Tochino Y, Funahashi T, et al. Increment and impairment of adiponectin in renal failure. Cardiovasc Res. 2010;86:471\u20137.","journal-title":"Cardiovasc Res"},{"key":"174_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1467-789X.2007.00439.x","volume":"9","author":"R Huxley","year":"2008","unstructured":"Huxley R, James WP, Barzi F, Patel JV, Lear SA, Suriyawongpaisal P, et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev. 2008;9:53\u201361.","journal-title":"Obes Rev"},{"key":"174_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1475-2840-12-88","volume":"12","author":"H Nagao","year":"2013","unstructured":"Nagao H, Kashine S, Nishizawa H, Okada T, Kimura T, Hirata A, et al. Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity. Cardiovasc Diabetol. 2013;12:88.","journal-title":"Cardiovasc Diabetol"},{"key":"174_CR34","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977\u201386.","journal-title":"N Engl J Med"},{"key":"174_CR35","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837\u201353.","journal-title":"Lancet"},{"key":"174_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0168-8227(00)00212-6","volume":"51","author":"Y Yoshida","year":"2001","unstructured":"Yoshida Y, Hagura R, Hara Y, Sugasawa G, Akanuma Y. Risk factors for the development of diabetic retinopathy in Japanese type 2 diabetic patients. Diabetes Res Clin Pract. 2001;51:195\u2013203.","journal-title":"Diabetes Res Clin Pract"},{"key":"174_CR37","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1167\/iovs.11-7208","volume":"52","author":"M Dirani","year":"2011","unstructured":"Dirani M, Xie J, Fenwick E, Benarous R, Rees G, Wong TY, et al. Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci. 2011;52:4416\u201321.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"174_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/2251-6581-13-55","volume":"13","author":"Z Maghbooli","year":"2014","unstructured":"Maghbooli Z, Pasalar P, Keshtkar A, Farzadfar F, Larijani B. Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy. J Diabetes Metab Disord. 2014;13:55.","journal-title":"J Diabetes Metab Disord"},{"issue":"12","key":"174_CR39","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.2337\/db11-1767","volume":"61","author":"C Kozuka","year":"2012","unstructured":"Kozuka C, Yabiku K, Sunagawa S, Ueda R, Taira S, Ohshiro H, et al. Brown rice and its component, \u03b3-oryzanol, attenuate the preference for high-fat diet by decreasing hypothalamic endoplasmic reticulum stress in mice. Diabetes. 2012;61(12):3084\u201393.","journal-title":"Diabetes"},{"issue":"4","key":"174_CR40","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409\u201339.","journal-title":"Physiol Rev"},{"issue":"Suppl 2","key":"174_CR41","first-page":"59","volume":"15","author":"S Fujioka","year":"1991","unstructured":"Fujioka S, Matsuzawa Y, Tokunaga K, Keno Y, Kobatake T, Tarui S. Treatment of visceral fat obesity. Int J Obes. 1991;15 Suppl 2:59\u201365.","journal-title":"Int J Obes"},{"key":"174_CR42","doi-asserted-by":"crossref","unstructured":"Zhang C, Luo H, Gao F, Zhang CT, Zhang R. A reduction in both visceral and subcutaneous fats contributes to increased adiponectin by lifestyle intervention in the Diabetes Prevention Program. Acta Diabetol. 2014, Oct 1. [Epub ahead of print]","DOI":"10.1007\/s00592-014-0655-2"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-015-0174-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0174-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0174-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0174-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:43:01Z","timestamp":1630568581000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-015-0174-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,16]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1186\/s12933-015-0174-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,16]]},"assertion":[{"value":"28 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}